SIOP is pleased to announce that the society is honoring Tim Eden with the 2020 SIOP Lifetime Achievement Award.
Having qualified from the University College and Hospital, London, in 1970, Tim held training posts in London, Portsmouth, Isle of Wight, Edinburgh and Stanford University, US. He was the first Consultant in Paediatric Haematology/Oncology appointed in Edinburgh in 1982. He was recruited to take up the first Chair of Paediatric Oncology at St Bartholomew’s Hospital, London in 1991. In 1994, he moved to Manchester University, Christie Hospital and the Royal Manchester Children’s Hospital, as their first CRUK Chair for Paediatric Oncology (1994-2005). In 2005, Manchester University was awarded by the Teenage Cancer Trust with the post of their first Chair in TYA Cancer to which Tim moved. He retired from clinical work in 2007 but continued as Professor doing research and enabling him to help as the Founding Medical Trustee to create a charity, World Child Cancer, to develop International Partnerships between established childhood and young adult centres in high income countries with those in low-middle income countries which were seeing increasing numbers of childhood cancer and asked for help. He was also the paediatric advisor to AfrOx and to the Commonwealth Scholarship Commission. Since 2010, he has been Emeritus Professor in Paediatric and Adolescent Oncology at Manchester University.
His research has included the creation, analysis and reporting of clinical trials, specifically for ALL and Lymphoma; the epidemiology and aetiology of childhood and adolescent cancer; the psychosocial functioning of young people and their families; and supportive care.
He has chaired national and international committees including as President of SIOP (2004 – 7), Chair of UKCCSG (now CCLG UK 1989-92), and of the Medical Research Council Childhood Leukaemia Working Party (1991 – 2000). He has published over 300 peer reviewed papers, editorials and book chapters on paediatric and adolescent haematology and oncology. Tim Eden says, “it has been a great privilege to have been working in the years where we went from not thinking we could treat and cure childhood cancers to over 85-90% survival certainly in ALL but many other tumours.”
For the last 13 years, Tim has focussed on the promotion of twinning between units/hospitals in high income countries and middle income countries to try to improve supportive, palliative and curative care for young people worldwide as firstly the medical trustee and deputy Chair and ongoing as Patron, Ambassador and Volunteer to the WCC. The first twinning was started in Malawi in 2009 and now there are 8 long term partnerships in Africa, Asia, and Central America. With SIOP there is a collaboration of 6 countries in sub-Sahara for Wilms tumour and supportive care. In 2018, I became an adviser to the 5-year WHO global initiative to improve the care and survival of childhood cancer.
Tim Eden joined SIOP in 1978 and had been an active member ever since, attending 30 of the SIOP meetings. In 1993, he joined the Scientific Committee and served 2 terms of 3 years each and was chair of SC for 1997 and 1998. In 2003, Tim was elected as President Elect and President from 2004-7. In Oslo 2004, Geoff Thaxter and Tim organised a symposium entitled “Two Worlds“ and after that, a team went to Bangladesh by request to assess the needs of all the units treating children with cancer in Dhaka. That gave birth to a joint SIOP and ICCCPO collaboration and that lead to WCC in 2007. He has been a member of the SIOP PODC for most of his time in SIOP. In 2010, PODC was reorganized and it has grown very fast and with many successes. His focus has been in the Essential Medicines group but we are still fighting a battle to ensure that all children with cancer can have availability, accessibility, affordable and effective care and with no contaminates. His hope is that we can overcome this problem.